Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 143.26
0.944 %
$ 14.5 B
Market Cap
38.2
P/E
NBIX - NET CHANGE IN CASH
Net Change in Cash NBIX - Neurocrine Biosciences, Inc.
-11.6 M
LAST VALUE
-3.70%
2 YEAR CAGR
36.46%
5 YEAR CAGR
4.80%
10 YEAR CAGR